Microfluidic encapsulation of enzymes and steroids within solid lipid nanoparticles.
Ontology highlight
ABSTRACT: The production of solid lipid nanoparticles (SLNs) is challenging, especially when considering the incorporation of biologics. A novel in-house method of microfluidic production of biologic-encapsulated SLNs is proposed, using a variety of base materials for formulation to help overcome the barriers presented during manufacture and administration. Trypsin is used as a model drug for hydrophilic encapsulation whilst testosterone is employed as a positive non-biologic lipophilic control active pharmaceutical ingredient. Particle sizes obtained ranged from 160 to 320 nm, and a lead formulation has been identified from the combinations assayed, allowing for high encapsulation efficiencies (47-90%, respectively) of both the large hydrophilic and the small hydrophobic active pharmaceutical ingre
SUBMITTER: Weaver E
PROVIDER: S-EPMC10746583 | biostudies-literature | 2024 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA